Aldeyra The (ALDX NASDAQ) stock market data APIs
$4.8375
0.1(2.1%)
as of November 6, 2025
Try our APIs with
free plan!
Aldeyra The Financial Data Overview
Price chart is built with
Anychart
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platform, including ADX 248, ADX 743, ADX 631, ADX 246, and other product candidates in development for inflammatory and metabolic diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Prev. Close
4.8375
Open
4.9382
High
4.966
Low
4.7796
52 wk Range
1.14-7.2
Market Cap
289 M
Shares Outstanding
60 163 K
EPS
-0.16
Beta
0.826
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Aldeyra The (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aldeyra The data using free add-ons & libraries
Get Aldeyra The Fundamental Data
Aldeyra The Fundamental data includes:
- Net Revenue:
- EBITDA: -53 061 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-08
- EPS/Forecast: -0.2433
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aldeyra The News
New
High Growth Tech Stocks In The US Market With Promising Potential
Amid a backdrop of record highs in major stock indexes and anticipation surrounding the Federal Reserve's interest rate decisions, the U.S. market is witnessing a dynamic phase where tech stocks are c...
US High Growth Tech Stocks To Watch Now
As major stock indexes in the United States reach record highs fueled by optimism over US-China trade discussions and expectations of a Federal Reserve interest rate cut, the tech sector continues to ...
High Growth Tech Stocks In US Market
The U.S. stock market has recently seen major indices like the Dow Jones, S&P 500, and Nasdaq reach new highs, driven by optimism surrounding U.S.-China trade talks and the potential for Federal Reser...
High Growth Tech Stocks In The US Market With Promising Potential
As the U.S. stock market navigates a period of volatility with major indexes snapping a three-day losing streak yet posting weekly losses, high growth tech stocks continue to capture investor interest...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
